SARS-CoV-2 Serosurvey in Addis Ababa, Ethiopia
- PMID: 32975182
- PMCID: PMC7646781
- DOI: 10.4269/ajtmh.20-0816
SARS-CoV-2 Serosurvey in Addis Ababa, Ethiopia
Abstract
In a serosurvey of asymptomatic people from the general population recruited from a clinical laboratory in May 2020 in Addis Ababa, Ethiopia, three of 99 persons tested positive for SARS-CoV-2 IgG (3.0%, 95% binomial exact confidence interval: 0.6-8.6%). Taking into account pretest probability and the sampling scheme, the range of plausible population prevalence values was approximately 1.0-8.4%. These results suggest that a larger number of people have been infected than the counts detected by surveillance to date; nevertheless, the results suggest the large majority of the general population in Addis Ababa currently is susceptible to COVID-19.
Conflict of interest statement
Disclosure: J. H. K. is a consultant (Data and Safety Monitoring Committee chair) for Gilead Sciences.
Figures

References
-
- Roberton T, Carter ED, Chou VB, Stegmuller AR, Jackson BD, Tam Y, Sawadogo-Lewis T, Walker N, 2020. Early estimates of the indirect effects of the COVID-19 pandemic on maternal and child mortality in low-income and middle-income countries: a modelling study. Lancet Glob Health 8: e901–e908. - PMC - PubMed
-
- Thornton J, 2020. COVID-19: Africa’s case numbers are rising rapidly, WHO warns. BMJ 369: m2394. - PubMed
-
- Tadesse L, 2020. Notification Note on COVID-19 Situational Update. Addis Ababa, Ethiopia: Ministry of Health Ethiopia.
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous